Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marieken J. Boer-Verschragen"'
Autor:
Marcia M. L. Kho, Willem Weimar, S. Reshwan K. Malahe, Joke M. Zuijderwijk, Ronella de Kuiper, Marieken J. Boer-Verschragen, Annemiek A. van der Eijk, Dennis A. Hesselink, Marlies E. J. Reinders, Nicole M. van Besouw
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundSolid organ transplant recipients are at high risk to develop (complicated) herpes zoster (HZ). Booster vaccination could prevent HZ. However, end-stage renal disease (ESRD) patients show poor immunological responses to vaccinations. We stu
Externí odkaz:
https://doaj.org/article/39a7faa097854fbcafbb3681e9bd4583
Autor:
Marcia M L Kho, A Lianne Messchendorp, Sophie C Frölke, Celine Imhof, Vera JCH Koomen, S Reshwan K Malahe, Priya Vart, Daryl Geers, Rory D de Vries, Corine H GeurtsvanKessel, Carla C Baan, Renate G van der Molen, Dimitri A Diavatopoulos, Ester B M Remmerswaal, Debbie van Baarle, Rob van Binnendijk, Gerco den Hartog, Aiko P J de Vries, Ron T Gansevoort, Frederike J Bemelman, Marlies E J Reinders, Jan-Stephan F Sanders, Luuk B Hilbrands, Alferso C. Abrahams, Marije C. Baas, Pim Bouwmans, Marc A.G.J. ten Dam, Lennert Gommers, Dorien Standaar, Marieke van der Heiden, Yvonne M.R. Adema, Marieken J. Boer-Verschragen, Wouter B. Mattheussens, Ria H.L.A. Philipsen, Djenolan van Mourik, Susanne Bogers, Laura L.A. van Dijk, Nynke Rots, Gaby Smits, Marjan Kuijer, Marc H. Hemmelder
Publikováno v:
Lancet Infectious Diseases, 23, 307-319
Lancet infectious diseases, 23(3), 307-319. Lancet Publishing Group
Lancet Infectious Diseases, 23(3), 307-319. ELSEVIER SCI LTD
The Lancet Infectious Diseases, 23(3), 307-319. Lancet Publishing Group
Lancet Infectious Diseases, 23, 3, pp. 307-319
Lancet infectious diseases, 23(3), 307-319. Lancet Publishing Group
Lancet Infectious Diseases, 23(3), 307-319. ELSEVIER SCI LTD
The Lancet Infectious Diseases, 23(3), 307-319. Lancet Publishing Group
Lancet Infectious Diseases, 23, 3, pp. 307-319
BACKGROUND: An urgent need exists to improve the suboptimal COVID-19 vaccine response in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with a control single dose mRNA-1273 vaccination: a double vaccine dose, he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0e83aaaad3fb6c01d134e2f61f346dd
https://pure.eur.nl/en/publications/7c01b0ca-5480-4d2b-acfb-2834cc7589ba
https://pure.eur.nl/en/publications/7c01b0ca-5480-4d2b-acfb-2834cc7589ba
Autor:
Willem Weimar, Nicole M. van Besouw, Ronella de Kuiper, J.M. Zuijderwijk, Marieken J. Boer-Verschragen, Marcia M. L. Kho, Annemiek A. van der Eijk
Publikováno v:
Vaccine, 35(1), 71-76. Elsevier
Background In immunocompromised patients, primary infection with VZV may have a disastrous clinical course. Vaccination of VZV-seronegative patients on the waiting list for renal transplantation may prevent severe disease. However, the immunologic re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76554fc364e255c06aca935dd4d4f87a
https://pure.eur.nl/en/publications/c90b54e0-501f-498a-85b8-78f4becfab92
https://pure.eur.nl/en/publications/c90b54e0-501f-498a-85b8-78f4becfab92
Autor:
Vervoort, J. P. M., Konijn, W. S., Jansen, D. E. M. C., Boersma, C., de Zeeuw, J., Ho-dac – Pannekeet, M. M., Gansevoort, R. T., Messchendorp, A. L., Sanders, J. S. F., de Wildt-Liesveld, R.
Publikováno v:
Research Involvement & Engagement; 9/13/2024, Vol. 10 Issue 1, p1-12, 12p
Publikováno v:
Transplant International; Sep2017 Supplement S2, Vol. 30, p8-164, 157p